TriangleNCT01964300 · OUTCOME
Sustained Objective Response (PR+CR) Rate Observed During the First Year of Treatment (for Stratum 1 Patients Only)
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- percentage of participants
- Interval / dispersion
- 95% Confidence Interval
- Time frame
- Up to 1 year
What was measured
Objective responses had to be sustained for 3 months. The percentage of participants with sustained objective responses is reported with an exact 95% confidence interval of the true sustained objective response rate.
Analysis population: The seven stratum 1 patients are included in this analysis. This outcome measure was a \*primary\* outcome measure for stratum 2 patients and is therefore reported as a separate outcome measure for stratum 2.
Groups in this outcome
Stratum 1
Stratum 1 patients are those with progressive unresectable or recurrent craniopharyngiomas treated with surgery alone, who had not received radiation therapy. Treatment consisted of Peginterferon alfa-2b (Sylatron) subcutaneously weekly for 6 weeks. Treatment may repeat every 6 weeks for up to 18 courses in the absence of disease progression or unacceptable toxicity.
Stratum 2
Stratum 2 patients are those with patients with progressive or recurrent craniopharyngiomas following radiation therapy. Treatment consisted of Peginterferon alfa-2b (Sylatron) subcutaneously weekly for 6 weeks. Treatment may repeat every 6 weeks for up to 18 courses in the absence of disease progression or unacceptable toxicity.
| Group | Source count |
|---|---|
| Stratum 1 | 7 |
| Stratum 2 | 0 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Stratum 1 | 14.3 | Not reported | 0.01 | 55.4 | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 0.01
- upper Limit
- 55.4
- value
- 14.3
- denoms
- counts
- group Id
- OG000
- value
- 7
- group Id
- OG001
- value
- 0
- units
- Participants
- description
- Objective responses had to be sustained for 3 months. The percentage of participants with sustained objective responses is reported with an exact 95% confidence interval of the true sustained objective response rate.
- dispersion Type
- 95% Confidence Interval
- groups
- description
- Stratum 1 patients are those with progressive unresectable or recurrent craniopharyngiomas treated with surgery alone, who had not received radiation therapy. Treatment consisted of Peginterferon alfa-2b (Sylatron) subcutaneously weekly for 6 weeks. Treatment may repeat every 6 weeks for up to 18 courses in the absence of disease progression or unacceptable toxicity.
- id
- OG000
- title
- Stratum 1
- description
- Stratum 2 patients are those with patients with progressive or recurrent craniopharyngiomas following radiation therapy. Treatment consisted of Peginterferon alfa-2b (Sylatron) subcutaneously weekly for 6 weeks. Treatment may repeat every 6 weeks for up to 18 courses in the absence of disease progression or unacceptable toxicity.
- id
- OG001
- title
- Stratum 2
- param Type
- NUMBER
- population Description
- The seven stratum 1 patients are included in this analysis. This outcome measure was a \*primary\* outcome measure for stratum 2 patients and is therefore reported as a separate outcome measure for stratum 2.
- reporting Status
- POSTED
- time Frame
- Up to 1 year
- title
- Sustained Objective Response (PR+CR) Rate Observed During the First Year of Treatment (for Stratum 1 Patients Only)
- type
- SECONDARY
- unit Of Measure
- percentage of participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice